Lu Yan

Lu Yan has worked at three companies in the past three years. In 2021, they were an Investigator I at H3 Biomedicine. In 2019, they were a Senior Scientist at AstraZeneca, where they had experience working on epigenetic protein degrader (PROTAC), and was involved in the synthesis and design of active and selective molecules using structure-based drug design. Lu is currently a Senior Scientist at Kojin Therapeutics.

Lu Yan attended Xiamen University from 2010 to 2014, where they earned a Bachelor's degree in Organic Chemistry. Lu then went on to pursue a Doctor of Philosophy - PhD in Organic Chemistry at Boston College, which they completed in 2019.